| Wang L et al. [10] | Zhu X et al. [11] | Lian J et al.
[12] | *Cheng B et al.
[13] | *Cheng B et al. [13] | Chen T et al. [14] | Liu K et al. [15] | Godaert L et al.
[16] | Liu Y et al.
[17] | Mi B et al.
[18] |
|---|
| Publication Month - 2020 | Mar | Mar | Mar | Apr | Apr | Apr | Mar | Apr | Mar | Apr | | Country | China | China | China | China | China | China | China | France | China | China | | No. Patients ≥60 Years Old | 339 | 114 | 136 | 67 | 51 | 55 | 18 | 17 | 7 | 6 | | Age | >60 | >70 | ≥60 | ≥60 | ≥60 | ≥65 | ≥60 | >67 | >61 | >75 | | Male No. | 166 | 67 | 58 | 22 | 31 | 34 | 12 | 8 | 4 | 2 | | Symptoms+ (%) | | | (92)
Fev | (82)
Fev | (85)
Fev | (74)
Cgh | (83)
Fev | (95)
Fev | (78)
Fev | (77)
Fev | (100)
Fev | (84)
Fev | | (53)
Cgh | (60)
Cgh | (63)
Cgh | (60)
Fev | (64)
Cgh | (70)
Cgh | (33)
Cgh | (70)
Cgh | (100)
Cgh | (84)
Cgh | | (41)
Dysp | (46)
Dysp | (36)
SP | (57)
CT | (64)
CT | (64)
CT | (33)
SP | (65)
Dysp | (58)
Chi | (67)
Dysp | | (40)
Ft | (45)
Ft | (18)
Ft | (48) Ft/Mya | (56) Ft/Mya | (60)
Dysp | (17)
N/V | (59)
Ft/Mya | (43)
Ft/Mya | (67)
Ft/Mya | | (28)
Anx | (33)
SP | (15)
Mya | (36)
SP | (48)
N/V | (20)
Mya | (11)
CT | (53)
Del | (14)
Dh | (50)
ST | | (28)
SP | (9)
Dh | (13)
ST | (21)
N/V | (26)
SP | (10)
Ft | (11)
Dysp | (36)
Dh | (14)
N/V | (33)
Dizz | | Others | (26) CT
(13) Dh | - | (13) Dysp (8) Dh
(6) Hdc | (14) Hdc (14) Diz | (12) Hdc
(12) Diz (6) Dh (10) Con (6) AG | (10) Anx
(6) Hdc (6) Dh (6) AP | (11) Ft/Mya (6) NC | (18) SP | - | (17) Hdc
(17) N/V (17) NC (17) CP (17) AP | | ≤5 % | Mya, Hdc,
N/V, Diz, Pha | Mya, N, V, Pha | NC, Hp | Dh, AG | - | N/V, CP | - | - | - | - | | Comorbidities++ (%) | | | (41)
HTN | (54) CVD | (39) HTN | (59) HTN | (50) HTN | (39) HTN | (46) Smo | - | (58) CVD | (50)
OP | | (16)
DM | (22) CLD | (18) DM | (17) DM | (32) DM | (22) DM | (28) HTN | - | (43) HTN | (33) HTN | | (16)
CVD | (22)
PS | (6) Smo | (17) CVD | (24) CVD | (20) CVD | (17) DM | - | (29) CRD | (17) DM | | (7)
CLD | (20)
CBD | - | (10) CLD | (12) CLD | (15)
CBD | (17) CVD | - | (14) DM | (17) CLD | | (7)
CBD | (19)
ED | - | | (6) CRD | (13) CLD | (6) CHD | - | (14) CLD | (17) CVD | | Others | - | - | - | - | - | (10) Mal (6) CRD | - | - | - | (17) ND
(17) BI (100) fracture patients | | ≤5 % | CHD,
CRD, Mal, AD | Mal | CLD, CVD, CRD, CHD, Mal, IC | CRD, CHD, Mal | - | CHD,
TB | - | - | - | - | | Radiological findings (%) | | | Description ° | - | - | (43)
GGO | - | - | (24)
PE | - | - | - | (100)
GGO/ Cons | | Single (S)/Multiple (M) lobe lesions | - | - | (42) M | - | - | (98) M | (89) M
(11) S | - | - | (100) M | | Distribution | | | Unilateral (U)/ Bilateral (BI) | - | - | (42) Bi
(11) U | - | - | (98)
Bi | (11)
U | - | - | - | | Central (C) / Peripheral (P)/ Both | - | - | - | - | - | - | - | - | - | - | | Outcome No. (%) | | | Healed/Discharged | 91 (27) | 87 (60) | 31 (23) | 67 (100) | - | - | 17
(95) | - | - | - | | Hospitalized | 183 (54) | - | 13 (10) °° | - | - | - | - | - | - | 2
(33) | | Death | 65 (19) | 27 (24) | - | - | 51 (100) | 19 (35) | 1
(6) | - | - | 4
(67) | | Days of Hospital Stay Duration - Median (IQR) | 28 (15-28) | - | - | - | - | 12 (1-45) | - | - | - | - |
| Niu S et al. a
[19] | Kerpel A et al.
[20] | Graselli G et al.
[21] | Zhu T et al.
[22] | Chen Z et al.
[23] | Guo T et al. [24] | **Sun H et al. [25] | **Sun H et al. [25] | Bruno G et al.
[26] | Gold J et al. [27] |
|---|
| Publication Month - 2020 | Apr | Apr | Apr | Mar | Mar | May | May | May | May | May | | Country | China | Israel | Italy | China | China | China | China | China | Italy | USA | | No. Patients ≥60 Years Old | 60 | 3 | 961 | 28 | 20 | 105 | 123 | 121 | 31 | 117 | | Age | ≥65 | 60-62 | ≥61 | >60 | ≥60 | ≥ 60 | ≥ 60 | ≥ 60 | ≥65 | ≥65 | | Male No. | 34 | 3 | 783 | 16 | - | 48 | 51 | 82 | 19 | - | | Symptoms+ (%) | | | (79)
Fev | (100) Fev | - | (86)
Fev | - | (67) Fev | (85)
Fev | (89)
Fev | (81)
Fev | - | | (57)
Cgh | (67) Cgh | - | (47)
Cgh | - | (65) Cgh | (74)
Cgh | (73)
Cgh | (81)
Cgh | - | | (30)
Dysp | (67) Ft/Mya | - | (33) Ft/Mya | - | (33)
Ft | (39)
GiS | (33)
GiS | (48)
Dysp | - | | (24) Ft/Mya | (33)
NC | - | (29)
Dysp | - | (30) Dysp | (29)
Dh | (30)
Dh | (19)
Ft | - | | (7)
Hdc | (33)
Syn | - | (22)
Dh | - | (10)
Dh | - | - | - | - | | | - | - | (22)
AP | - | (8)
Mya | - | - | - | - | | Others | - | - | - | - | - | (6)
N/V | - | - | - | - | | ≤5 % | - | - | - | - | - | Hdc,
Anx | AP | AP | GiS,
AP | - | | Comorbidities++ (%) | | | (48) HTN | (67) HTN | (38) HTN | - | - | (44)
HTN | (55)
HTN | (63)
HTN | (87)
HTN | (86)
HTN | | (29) CLD | (67) Smo | (18) CVD | - | - | (26)
DM | (20)
DM | (22)
DM | (26)
Smo | (47)
CVD | | (16) CVD | (33) DM | (16)
HC | - | - | (16)
CVD | (12)
CVD | (17)
CLD | (16)
CLD | (44)
DM | | (10)
DM | (33) CVD | (14) DM | - | - | (12)
Smo | - | (17)
CVD | (16)
CVD | (21)
CKD | | (6)
CBD | (33)
PS | (8) Mal | - | - | (9)
CLD | - | - | (13)
DM | (19)
CLD | | Others | - | (33)
DL | (15)
NS | - | - | - | - | - | (9)
CKD | - | | ≤5 % | - | - | CLD, CRD, CHD | - | - | CLD,
CKD | CLD,
CBD | - | Mal | Smo,
Mal | | Radiological findings (%) | | | Description ° | - | (67)
Cons | - | (89)
GGO/ Cons (54) GGO (22) Cons (7) PE | - | (40)
GGO | - | - | (65)
GGO/Cons (32) Cons | - | | Single (S)/Multiple (M) lobe lesions | - | (100) M | - | (93)M
(7) S | (65)M | (89)M | - | - | - | - | | Distribution | | | Unilateral (U)/ Bilateral (BI) | - | (100)
Bi | - | - | (65)
Bi (35) U | (89)
Bi (1) U | - | - | (96)
Bi (3) U | - | | Central (C) / Peripheral (P)/ Both | - | (67) P | - | (60) P
(36) Both | - | - | - | - | - | - | | Outcome No. (%) | | | Healed/Discharged | 23
(38) | 1
(33) | 111 (12) | - | - | 90
(86) | 123
(100) | - | 7
(23) | 65
(56) | | Hospitalized | 32
(53) | 2
(67) | 525 (55) °° | - | - | 12
(11) | - | - | 18
(58) | 16 | | Death | 5
(9) | - | 322 (34) | - | - | 3
(3) | - | 121
(100) | 6
(19) | 36
(31) | | Days of Hospital Stay Duration - Median (IQR) | - | - | - | - | - | 17
(13-23) | - | - | 23
(16-30) | 10
(6-16) |
|